Toothache
Conditions
Interventions
This is a double-blind, parallel, randomized controlled clinical trial that will be conducted with a sample of 48 patients diagnosed with an acute dentoalveolar abscess in evolution who report pain gr
Sponsors
Universidade Federal do Rio Grande do Sul
Universidade Federal do Rio Grande do Sul
Eligibility
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Patients aged 18 to 55 years; diagnosis of acute dentoalveolar abscess in evolution; pain score equal to or greater than 40 mm in the Visual Analog Scale, at the time of initial care
Exclusion criteria
Exclusion criteria: Patients allergic to the drugs used in the present study; chronic use of opioids, steroid anti-inflammatories, antidepressants; history of liver disease; rheumatoid arthritis; severe heart disease; diagnosis of depression/anxiety; pregnant or lactating women; alcoholics; current or former users of substances such as crack, oxy, cocaine, marijuana and solvents; chronic pain; difficulties in understanding the scales
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the pain scores at 0, 6, 12, 24, 48 and 72 hours after ingestion of the first dose of analgesic, using the Visual Analog Scale, of patients with acute dentoalveolar abscess in evolution. | — |
Secondary
| Measure | Time frame |
|---|---|
| Observe the frequency of adverse reactions eventually described by patients. | — |
Countries
Brazil
Contacts
Public ContactMarcus Vinicius Só
Universidade Federal do Rio Grande do Sul
Outcome results
None listed